V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220005688 | 220002228 | null | 69.8 | Curative (C) | 2014-11-19 | 2014-12-09 | AML17 TRIAL | N | N | 220028736 | AML17 TRIAL |
| 220005689 | 220002228 | 0 | 80 | null | 2016-12-20 | 2016-12-20 | Cytarabine Low Dose | null | N | 220028736 | CYTARABINE |
| 220005690 | 220002228 | null | null | Palliative (P) | 2013-08-26 | 2013-09-23 | Cytarabine Low Dose | N | N | 220028736 | CYTARABINE |
| 220005691 | 220002228 | null | 65 | Palliative (P) | 2016-07-14 | 2016-07-14 | CYTARABINE | 02 | null | 220028736 | CYTARABINE |
| 220005692 | 220002228 | null | null | null | 2017-06-13 | 2017-06-13 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220028736 | CYTARABINE |
| 220005693 | 220002228 | null | 70 | Curative (C) | 2013-04-29 | 2013-05-01 | AML17 TRIAL | 01 | N | 220028736 | AML17 TRIAL |
| 220005694 | 220002228 | 1.63 | 0 | Neo-adjuvant (N) | 2014-02-21 | 2014-03-02 | Cytarabine Low Dose | N | null | 220028736 | CYTARABINE |
| 220005697 | 220002230 | 1.66 | 0 | Curative (C) | 2016-12-13 | 2016-12-13 | Trial Unspecified | 1 | N | 220028761 | TRIAL |
| 220005698 | 220002230 | 1.69 | 78.8 | Not known (9) | 2017-02-11 | 2017-02-15 | AML17 TRIAL | N | N | 220028761 | AML17 TRIAL |
| 220005699 | 220002231 | 1.68 | 57.8 | Curative (C) | 2016-03-12 | 2016-03-12 | AML17 TRIAL | 01 | N | 220028764 | AML17 TRIAL |
| 220005700 | 220002232 | 1.68 | 67.2 | Not known (9) | 2014-09-23 | 2014-10-13 | AML17 TRIAL | N | N | 220028768 | AML17 TRIAL |
| 220005701 | 220002232 | 1.88 | 82.3 | Not known (9) | 2016-05-11 | 2016-05-13 | AML17 TRIAL | N | N | 220028768 | AML17 TRIAL |
| 220005702 | 220002233 | 1.62 | null | Curative (C) | 2015-03-25 | 2015-03-25 | AML17 TRIAL | Y | N | 220028771 | AML17 TRIAL |
| 220005703 | 220002233 | null | 77.5 | Curative (C) | null | 2013-07-19 | AML17 TRIAL | N | N | 220028771 | AML17 TRIAL |
| 220005704 | 220002234 | 1.71 | null | Palliative (P) | 2016-10-07 | 2016-10-07 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220028776 | CYTARABINE |
| 220005705 | 220002234 | 1.8 | null | Curative (C) | 2013-09-18 | 2013-09-18 | AML17 TRIAL | 1 | N | 220028776 | AML17 TRIAL |
| 220005706 | 220002234 | 1.8 | 0 | null | 2014-12-01 | 2014-12-02 | Trial Unspecified | Y | N | 220028776 | TRIAL |
| 220005707 | 220002235 | 1.82 | 89.25 | Curative (C) | 2017-04-24 | 2017-04-24 | Trial Unspecified | 01 | null | 220028781 | TRIAL |
| 220005708 | 220011228 | null | 97.9 | null | 2017-10-23 | 2017-10-23 | Trial Unspecified | 01 | null | 220028782 | TRIAL |
| 220005709 | 220011228 | null | 73.4 | Curative (C) | 2014-01-25 | 2014-01-25 | Trial Unspecified | 1 | null | 220028782 | TRIAL |
| 220005710 | 220011228 | null | 86.8 | Curative (C) | 2014-06-19 | 2014-06-20 | Trial Unspecified | 01 | N | 220028782 | TRIAL |
| 220005711 | 220011228 | 1.66 | 55 | Curative (C) | 2014-10-20 | 2014-11-03 | Trial Unspecified | null | N | 220028782 | TRIAL |
| 220005713 | 220002237 | 1.75 | 60 | Curative (C) | 2017-04-17 | 2017-04-24 | AML17 TRIAL | N | N | 220028792 | AML17 TRIAL |
| 220005714 | 220011229 | 0 | null | Curative (C) | 2013-11-23 | 2013-11-27 | Trial Unspecified | 01 | N | 220028794 | TRIAL |
| 220005715 | 220011229 | null | 60.5 | Curative (C) | 2016-03-09 | 2016-03-09 | Trial Unspecified | Y | N | 220028794 | TRIAL |
| 220005716 | 220011229 | null | null | Curative (C) | 2016-02-14 | 2016-02-18 | Nilotinib | 02 | N | 220028794 | NILOTINIB |
| 220005717 | 220002238 | null | null | Palliative (P) | 2013-01-22 | 2013-01-22 | Nilotinib | 2 | N | 220028801 | NILOTINIB |
| 220005718 | 220011230 | 1.52 | 0 | Disease modification (D) | 2015-04-07 | 2015-04-07 | Nilotinib | N | N | 220028802 | NILOTINIB |
| 220005719 | 220002239 | 1.71 | 80.3 | Curative (C) | 2013-06-16 | 2013-06-16 | AML 19 TRIAL | Y | N | 220028803 | AML19 TRIAL |
| 220005720 | 220002239 | 1.78 | 81 | Adjuvant (A) | 2016-11-30 | 2016-12-01 | FLAG + Idarubicin | N | N | 220028803 | FLAG + IDARUBICIN |
| 220005721 | 220016017 | 1.78 | 85 | null | 2017-08-12 | 2017-08-18 | FLAG + Idarubicin | N | N | 220028807 | FLAG + IDARUBICIN |
| 220005722 | 220016017 | 1.7 | 83.5 | Not known (9) | 2017-05-16 | 2017-05-17 | Nilotinib | N | N | 220028807 | NILOTINIB |
| 220005723 | 220016017 | 1.63 | 101.4 | Curative (C) | 2016-09-29 | 2016-09-29 | FLAG + Idarubicin | 99 | N | 220028807 | FLAG + IDARUBICIN |
| 220005724 | 220002240 | null | null | Curative (C) | 2018-05-26 | 2018-05-30 | Nilotinib | N | N | 220028815 | NILOTINIB |
| 220005725 | 220011232 | 1.66 | 77 | Neo-adjuvant (N) | 2015-07-07 | 2015-07-08 | AML 19 TRIAL | Y | N | 220028822 | AML19 TRIAL |
| 220005726 | 220002241 | 1.6 | null | Curative (C) | 2014-09-13 | 2014-09-20 | FLAG + Idarubicin | 2 | N | 220028823 | FLAG + IDARUBICIN |
| 220005727 | 220002241 | 1.7 | 85.6 | Curative (C) | 2017-01-15 | 2017-01-15 | FLAG + Idarubicin | null | null | 220028823 | FLAG + IDARUBICIN |
| 220005728 | 220002241 | 1.75 | 65 | Curative (C) | 2015-07-12 | 2015-07-12 | AML 19 TRIAL | 1 | N | 220028823 | AML19 TRIAL |
| 220005729 | 220002241 | 1.71 | null | Curative (C) | 2013-01-13 | 2013-01-13 | null | N | N | 220028823 | NOT MATCHED |
| 220005730 | 220002241 | 1.87 | 0 | null | 2018-01-02 | 2018-02-01 | Nilotinib | N | N | 220028823 | NILOTINIB |
| 220005731 | 220002242 | 1.69 | 87.2 | Curative (C) | 2016-06-09 | 2016-06-10 | AML 19 TRIAL | Y | N | 220028837 | AML19 TRIAL |
| 220005732 | 220002242 | 1.61 | 76.7 | Curative (C) | 2016-06-04 | 2016-06-04 | Nilotinib | N | N | 220028837 | NILOTINIB |
| 220005733 | 220002243 | 0 | 60.25 | Curative (C) | 2014-02-06 | 2014-02-07 | NB HRNBL-1 COJEC Ind COURSE A | N | N | 220028840 | NOT MATCHED |
| 220005734 | 220002243 | null | null | Curative (C) | 2015-10-28 | 2015-10-31 | Nilotinib | 2 | N | 220028840 | NILOTINIB |
| 220005735 | 220002243 | 0 | 0 | Curative (C) | 2013-11-18 | 2013-11-18 | Nilotinib | N | N | 220028840 | NILOTINIB |
| 220005736 | 220002243 | 1.71 | 83.2 | Curative (C) | 2015-05-18 | 2015-05-18 | AML 19 TRIAL | Y | N | 220028840 | AML19 TRIAL |
| 220005737 | 220002243 | 1.66 | 63.2 | Curative (C) | 2016-03-31 | 2016-04-01 | AML 19 TRIAL | Y | N | 220028840 | AML19 TRIAL |
| 220005738 | 220002243 | 0 | 55.9 | Curative (C) | 2015-03-09 | 2015-03-24 | Nilotinib | N | N | 220028840 | NILOTINIB |
| 220005739 | 220002243 | 1.74 | null | Disease modification (D) | 2016-04-15 | 2016-04-15 | Nilotinib | N | N | 220028840 | NILOTINIB |
| 220005740 | 220002244 | 1.7 | 74 | Curative (C) | 2014-12-27 | 2014-12-27 | AML 19 TRIAL | 01 | null | 220028859 | AML19 TRIAL |